Three companies recently announced progression in their clinical research for next-generation Covid-19 vaccines: INOVIO, ...

The Viral Vector & Plasmid DNA Manufacturing Market Size accounted for USD 5.4 Billion in 2023 and is estimated to achieve a ...

TASS/. Mass vaccination with a coronavirus vaccine developed by Russia’s State Research Center of Virology and Biotechnology Vector is expected to take place in 2021, the center's Director ...

With a viral vector, there is essentially a viral particle ... for the production of the full-length spike protein of the coronavirus. It then elicits an immune response against that spike ...

A recent CIA assessment has again fuelled the Wuhan lab-leak conspiracy theory. But extraordinary claims require extraordinary evidence – and it simply isn’t there ...

An inhalable version of a single-shot, adenovirus-based viral vector vaccine might provide a new option for COVID-19 vaccination. In October 2021, the World Health Organization set a target for ...

have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza ...

As the world becomes accustomed to living with COVID-19, is there a chance that ... This includes direct contact, indirect contact (through a vector like a mosquito or tick), through food, and ...

AZD1222, developed by the University of Oxford and licenced to AstraZeneca, was among the first vaccines created to protect against COVID-19. A non -replicating viral vector vaccine which was ...

Researchers have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 ...

Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic, this platform ...